-
1
-
-
0027395834
-
Erythropoietin production by the kidney
-
Koury S, Koury ML. Erythropoietin production by the kidney. Semin Nephrol 1993;12:78-86.
-
(1993)
Semin. Nephrol.
, vol.12
, pp. 78-86
-
-
Koury, S.1
Koury, M.L.2
-
2
-
-
0031755934
-
Biology of erythropoietin
-
Lacombe C, Mayeurx P. Biology of erythropoietin. Haematologica 1998;83:724-732.
-
(1998)
Haematologica
, vol.83
, pp. 724-732
-
-
Lacombe, C.1
Mayeurx, P.2
-
3
-
-
0025297296
-
Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells
-
Anagostou A, Lee ES, Kessimiar N, et al. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990;87:5978-5982.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 5978-5982
-
-
Anagostou, A.1
Lee, E.S.2
Kessimiar, N.3
-
4
-
-
0027302375
-
Functional erythropoietin receptor of the cells with neural characteristics: Comparison with receptor properties of erythroid cells
-
Masuda S, Nagao J, Takahata K, et al. Functional erythropoietin receptor of the cells with neural characteristics: comparison with receptor properties of erythroid cells. J Biol Chem 1993;268:11208-11216.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 11208-11216
-
-
Masuda, S.1
Nagao, J.2
Takahata, K.3
-
5
-
-
0033561341
-
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and simulates neovascularization in vivo
-
Ribatti D, Preset M, Vacca A, et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and simulates neovascularization in vivo. Blood 1999;93:2627-2636.
-
(1999)
Blood
, vol.93
, pp. 2627-2636
-
-
Ribatti, D.1
Preset, M.2
Vacca, A.3
-
6
-
-
0032566597
-
Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis
-
Yasuda Y, Masuda S, Chikuma M, et al. Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem 1998;273:25381-25387.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 25381-25387
-
-
Yasuda, Y.1
Masuda, S.2
Chikuma, M.3
-
7
-
-
0032516086
-
In vivo evidence that erythropoietin protects neurons from ischemic damage
-
Sakanaka M, Wen TC, Matsuda S, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998;95:4635-4640.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 4635-4640
-
-
Sakanaka, M.1
Wen, T.C.2
Matsuda, S.3
-
8
-
-
0029007084
-
Localization of specific erythropoietin binding sites in defined areas of the mouse brain
-
Digcaylioglu M, Bichet S, Marti HH, et al. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 1995;92:3717-3720.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 3717-3720
-
-
Digcaylioglu, M.1
Bichet, S.2
Marti, H.H.3
-
9
-
-
0031037376
-
Detection of erythropoietin in human liquor: Intrinsic erythropoietin production in the brain
-
Marti HH, Gassmann M, Wenger RH, et al. Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int 1997;51;416-418.
-
(1997)
Kidney Int.
, vol.51
, pp. 416-418
-
-
Marti, H.H.1
Gassmann, M.2
Wenger, R.H.3
-
10
-
-
0030636320
-
Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death
-
Morishita E, Masuda S, Nagao M, et al. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997;76:105-116.
-
(1997)
Neuroscience
, vol.76
, pp. 105-116
-
-
Morishita, E.1
Masuda, S.2
Nagao, M.3
-
11
-
-
18144436505
-
Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus
-
Juul SE, Yachnis AT, Christensen RD:Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 1998;52:235-249.
-
(1998)
Early Hum. Dev.
, vol.52
, pp. 235-249
-
-
Juul, S.E.1
Yachnis, A.T.2
Christensen, R.D.3
-
12
-
-
0034284026
-
Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity
-
Sinor AD, Greenberg DA. Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci Lett 2000;290:213-215.
-
(2000)
Neurosci. Lett.
, vol.290
, pp. 213-215
-
-
Sinor, A.D.1
Greenberg, D.A.2
-
13
-
-
0033512017
-
A potential role for erythropoietin in focal permanent cerebral ischemia in mice
-
Bernaudin M, Marti HH, Roussel S, et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999;19:643-651.
-
(1999)
J. Cereb. Blood Flow. Metab.
, vol.19
, pp. 643-651
-
-
Bernaudin, M.1
Marti, H.H.2
Roussel, S.3
-
15
-
-
0037117577
-
Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage
-
Grasso G, Buemi M, Alafaci C. Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci USA 2002;99:5627-5631.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 5627-5631
-
-
Grasso, G.1
Buemi, M.2
Alafaci, C.3
-
16
-
-
0036177399
-
A single subcutaneous bolus of erythropoietin normalized cerebral blood flow autoregulation after subarachnoid haemorrhage in rats
-
Springborg JB, Ma X, Rochat P, et al. A single subcutaneous bolus of erythropoietin normalized cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol 2002;135:823-829.
-
(2002)
Br. J. Pharmacol.
, vol.135
, pp. 823-829
-
-
Springborg, J.B.1
Ma, X.2
Rochat, P.3
-
17
-
-
0034928578
-
Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage
-
Grasso G. Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. J Neurosurg Sci 2001;45:7-14.
-
(2001)
J. Neurosurg. Sci.
, vol.45
, pp. 7-14
-
-
Grasso, G.1
-
18
-
-
0011483837
-
Erythropoietin crosses the blood brain barrier: An analysis in a nonhuman primate model
-
[abstract 4265]
-
Farrell F, Juul S, Elliott C, et al. Erythropoietin crosses the blood brain barrier: an analysis in a nonhuman primate model [abstract 4265]. Blood 2001;98(suppl 1):148b.
-
(2001)
Blood
, vol.98
, Issue.SUPPL. 1
-
-
Farrell, F.1
Juul, S.2
Elliott, C.3
-
19
-
-
0036726257
-
Erythropoietic agents as neurotherapeutic agents: What barriers exist?
-
Jumbe NL. Erythropoietic agents as neurotherapeutic agents: what barriers exist? Oncology 2002;16:91-107.
-
(2002)
Oncology
, vol.16
, pp. 91-107
-
-
Jumbe, N.L.1
-
20
-
-
0037086295
-
Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression
-
Wen TC, Sadamoto Y, Tanaka J, et al. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J Neurosci Res 2002;67:795-803.
-
(2002)
J. Neurosci. Res.
, vol.67
, pp. 795-803
-
-
Wen, T.C.1
Sadamoto, Y.2
Tanaka, J.3
-
21
-
-
0033597715
-
Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: A direct role for Stat5 in Bcl-X(L) induction
-
Socolovsky M, Fallon AE, Wang S, et al. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 1999;98:181-189.
-
(1999)
Cell
, vol.98
, pp. 181-189
-
-
Socolovsky, M.1
Fallon, A.E.2
Wang, S.3
-
22
-
-
0033018511
-
Effects of erythropoietin on neuronal activity
-
Koshimura K, Maurakami Y, Sohmiya M, et al. Effects of erythropoietin on neuronal activity. J Neurochem 1999;72:2565-2572.
-
(1999)
J. Neurochem.
, vol.72
, pp. 2565-2572
-
-
Koshimura, K.1
Maurakami, Y.2
Sohmiya, M.3
-
23
-
-
0034627241
-
Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells
-
Kawakami M, Iwasaki S, Sato K, et al: Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells. Biochem Biophys Res Commun 2000;279:293-297.
-
(2000)
Biochem. Biophys. Res. Commun.
, vol.279
, pp. 293-297
-
-
Kawakami, M.1
Iwasaki, S.2
Sato, K.3
-
24
-
-
0033615544
-
Mitochondrial nitric oxide synthetase stimulation causes cytochrome C release from isolated mitochondria
-
Ghafourihar P, Schenk U, Klein SD et al. Mitochondrial nitric oxide synthetase stimulation causes cytochrome C release from isolated mitochondria. J Biol Chem 1999;274:31185-31188.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 31185-31188
-
-
Ghafourihar, P.1
Schenk, U.2
Klein, S.D.3
-
25
-
-
0036981235
-
Rationale for a phase III study of erythropoietin as a neurocognitive protectant in patients with lung cancer receiving prophylactic cranial radiation
-
Senzer N. Rationale for a phase III study of erythropoietin as a neurocognitive protectant in patients with lung cancer receiving prophylactic cranial radiation. Semin Oncol 2002;29:47-52.
-
(2002)
Semin. Oncol.
, vol.29
, pp. 47-52
-
-
Senzer, N.1
-
26
-
-
0032516086
-
In vivo evidence that erythropoietin protects neurons from ischemic damage
-
Sakanaka M, Wen TC, Matsuda S, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998;95:4635-4640.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 4635-4640
-
-
Sakanaka, M.1
Wen, T.C.2
Matsuda, S.3
-
27
-
-
0030856362
-
Erythropoietin is present in the cerebrospinal fluid of neonates
-
Juul SE, Harcum J, Li Y, et al: Erythropoietin is present in the cerebrospinal fluid of neonates. J Pediatr 1997;130:428-430.
-
(1997)
J. Pediatr.
, vol.130
, pp. 428-430
-
-
Juul, S.E.1
Harcum, J.2
Li, Y.3
-
28
-
-
0032753235
-
Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury
-
Juul SE, Stallings SA, Christensen RD. Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury. Pediatr Res 1999;46: 543-547.
-
(1999)
Pediatr. Res.
, vol.46
, pp. 543-547
-
-
Juul, S.E.1
Stallings, S.A.2
Christensen, R.D.3
-
29
-
-
0034641710
-
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
-
Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000;97:10526-10531.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 10526-10531
-
-
Brines, M.L.1
Ghezzi, P.2
Keenan, S.3
-
30
-
-
0027287837
-
Endothelial cell biology and the enigma of transcytosis through the blood-brain barrier
-
Broadwell RD. Endothelial cell biology and the enigma of transcytosis through the blood-brain barrier. Adv Up Med Biol 1993;331:137-141.
-
(1993)
Adv. Up. Med. Biol.
, vol.331
, pp. 137-141
-
-
Broadwell, R.D.1
-
31
-
-
0030025496
-
Chronic treatment with human recombinant erythropoietin increases hematocrit and improves water maze performance in mice
-
Hengemihle JM, Abugo O, Rifkind J, et al. Chronic treatment with human recombinant erythropoietin increases hematocrit and improves water maze performance in mice. Physiol Behav 1996;59:153-156.
-
(1996)
Physiol. Behav.
, vol.59
, pp. 153-156
-
-
Hengemihle, J.M.1
Abugo, O.2
Rifkind, J.3
-
32
-
-
0037154573
-
Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils
-
Catania MA, Marciano MC, Parisi A, et al. Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur J Pharmacol 2002;437:147-150.
-
(2002)
Eur. J. Pharmacol.
, vol.437
, pp. 147-150
-
-
Catania, M.A.1
Marciano, M.C.2
Parisi, A.3
-
33
-
-
0027435490
-
Effects of rHuEPO on Q-EEG and event related potentials in chronic renal failure
-
Sagales T, Gimeno V, Planella MJ, et al. Effects of rHuEPO on Q-EEG and event related potentials in chronic renal failure. Kidney Int 1993;44:1109-1115.
-
(1993)
Kidney Int.
, vol.44
, pp. 1109-1115
-
-
Sagales, T.1
Gimeno, V.2
Planella, M.J.3
-
34
-
-
0033824494
-
Benefits of anaemia treatment on cognitive function
-
Stivelman JC. Benefits of anaemia treatment on cognitive function. Nephrol Dial Transplant 2000;15(suppl 3):29-35.
-
(2000)
Nephrol. Dial. Transplant.
, vol.15
, Issue.SUPPL. 3
, pp. 29-35
-
-
Stivelman, J.C.1
-
36
-
-
0033054185
-
Normalizing hematocrit in dialysis patients improves brain function
-
Pickett JL, Theberge DC, Brown WS, et al. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis 1999;33: 1122-1130.
-
(1999)
Am. J. Kidney Dis.
, vol.33
, pp. 1122-1130
-
-
Pickett, J.L.1
Theberge, D.C.2
Brown, W.S.3
-
37
-
-
0029152037
-
Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation
-
Komacki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995;33:179-182.
-
(1995)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.33
, pp. 179-182
-
-
Komacki, R.1
Meyers, C.A.2
Shin, D.M.3
-
38
-
-
0031596928
-
Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: A study by the Cancer and Leukemia Group
-
Ahles TA, Silberfarb PM, Herdon J, et al. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group. Br J Clin Oncol 1998;16: 1954-1960.
-
(1998)
Br. J. Clin. Oncol.
, vol.16
, pp. 1954-1960
-
-
Ahles, T.A.1
Silberfarb, P.M.2
Herdon, J.3
-
39
-
-
0032481412
-
Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy
-
van Dam FS,Schagen SB, Muller M, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:182, 183, 210-218.
-
(1998)
J. Natl. Cancer Inst.
, vol.90
, Issue.182-183
, pp. 210-218
-
-
van Dam, F.S.1
Schagen, S.B.2
Muller, M.3
-
40
-
-
0033082318
-
Cognitive defects after postoperative adjuvant chemotherapy of breast carcinoma
-
Schagen S, van Dam F, Muller M, et al. Cognitive defects after postoperative adjuvant chemotherapy of breast carcinoma. Cancer 1999;85:640-650.
-
(1999)
Cancer
, vol.85
, pp. 640-650
-
-
Schagen, S.1
van Dam, F.2
Muller, M.3
-
41
-
-
0033942083
-
Cognitive function in breast cancer patients receiving adjuvant chemotherapy
-
Brezden C, Phillips KA, et al. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000;18:2695-2701.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 2695-2701
-
-
Brezden, C.1
Phillips, K.A.2
-
43
-
-
0032702933
-
Toxic leukoencephalopathy
-
Filley CM.Toxic leukoencephalopathy. Clin Neuropharmacol 1999;22:249-260.
-
(1999)
Clin. Neuropharmacol.
, vol.22
, pp. 249-260
-
-
Filley, C.M.1
-
45
-
-
0031800607
-
The behavioral neurology of cerebral white matter
-
Filley CM.The behavioral neurology of cerebral white matter. Neurology 1998;50:1535-1540.
-
(1998)
Neurology
, vol.50
, pp. 1535-1540
-
-
Filley, C.M.1
-
47
-
-
0036705708
-
Erythropoietin therapy for acute stroke is both safe and beneficial
-
Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002;8:495-505.
-
(2002)
Mol. Med.
, vol.8
, pp. 495-505
-
-
Ehrenreich, H.1
Hasselblatt, M.2
Dembowski, C.3
-
48
-
-
0012650526
-
Effects of epoetin alfa on cognitive function, mood, asthenia and quality of life in women with breast cancer undergoing adjuvant chemotherapy
-
O'Shaughnessy J. Effects of epoetin alfa on cognitive function, mood, asthenia and quality of life in women with breast cancer undergoing adjuvant chemotherapy. Clin Breast Cancer 2002;3:S116-S120.
-
(2002)
Clin. Breast Cancer
, vol.3
-
-
O'Shaughnessy, J.1
|